EUVIMEDOpdag EUVIMED
Open access

Photodynamic Diagnosis for Superficial Bladder Cancer: Do All Risk-Groups Profit Equally from Oncological and Economic Long-Term Results?

Wolfgang Otto, Maximilian Burger, Hans-Martin Fritsche, Andreas Blana, Wolfgang Roessler, Ruth Knuechel, Wolf F Wieland, Stefan Denzinger

Clinical medicine. Oncology · 2009

DOI: 10.4137/cmo.s1012 ↗

At a glance

Journal article in Clinical medicine. Oncology, 2009. Written by Wolfgang Otto and 7 co-authors. Institution: Department of Urology, University of Regensburg, Germany. Cited 2 times so far (Crossref); 28 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

Photodynamic diagnosis (PDD) of superficial bladder cancer decreases recurrence rates. We present oncological results of a randomized, prospective study, comparing transurethral resection (TUR) performed under conventional white light (WL) with PDD. The follow-up period is the longest reported to date. As costs might be reimbursed by prolonged recurrence-free survival in certain patients cost analysis in regard to risk-groups was performed. Material and methods Using chi-square test and log-rank test we compared recurrence rates of 103 patients after WL-TUR and of 88 patients after PDD-TUR. Cost analysis was performed according to risk-groups of recurrence.

Results

Mean follow-up was 99 months. Recurrence rate was 57% in WL vs. 28% in PDD (p < 0.001). Costs incurred by subsequent TUR averaged € 2310 per WL patient vs. € 713 per PDD patient. Savings per patient by PDD amounted to € 1597. PDD costs were reimbursed in low, intermediate and high risk patients, respectively.

Conclusions

PDD-TUR is significantly superior to conventional WL-TUR in terms of recurrence rate. While economic benefit is most prominent in intermediate risk patients, PDD related costs are reimbursed in all risk-groups.

Subjects

Author keywords

cost analysisphotodynamicrecurrence ratesuperficial bladder cancertransurethral resectionurothelial carcinoma

Authors and institutions

  • Department of Urology, University of Regensburg, Germany.

Cite

APA

Otto, W., Burger, M., Fritsche, H. M., Blana, A., Roessler, W., Knuechel, R., Wieland, W. F., & Denzinger, S. (2009). Photodynamic Diagnosis for Superficial Bladder Cancer: Do All Risk-Groups Profit Equally from Oncological and Economic Long-Term Results?. Clinical medicine. Oncology. https://doi.org/10.4137/cmo.s1012

Vancouver

Otto W, Burger M, Fritsche HM, Blana A, Roessler W, Knuechel R, et al. Photodynamic Diagnosis for Superficial Bladder Cancer: Do All Risk-Groups Profit Equally from Oncological and Economic Long-Term Results?. Clinical medicine. Oncology. 2009. doi:10.4137/cmo.s1012

BibTeX
@article{Otto2009,
  author = {Otto, Wolfgang and Burger, Maximilian and Fritsche, Hans-Martin and Blana, Andreas and Roessler, Wolfgang and Knuechel, Ruth and Wieland, Wolf F and Denzinger, Stefan},
  title = {Photodynamic Diagnosis for Superficial Bladder Cancer: Do All Risk-Groups Profit Equally from Oncological and Economic Long-Term Results?},
  journal = {Clinical medicine. Oncology},
  year = {2009},
  doi = {10.4137/cmo.s1012}
}
Start for free →